Search results for 'chemotherapy'

Britons forced to go private for chemotherapy as NHS misses treatment targets

The NHS has missed its two main cancer targets this year, with just two-thirds of patients receiving a diagnosis and first treatment within 62 days after an urgent referral. Read more

Mail Online - Dec 21

Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. Read more

Medical News - Dec 08

Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. Read more

Medical News - Dec 08

Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40 percent increase in overall survival in a landmark trial of 34 patients led by University of Maryland School of Medicine (UMSOM) researchers. Read more

Medical News - Nov 25

Light-based cancer treatment could offer safer alternative to chemotherapy

Chemotherapy and radiotherapy often leave patients exhausted and vulnerable to long-term side effects Read more

The Independent - Nov 24

Scientists uncover molecular mechanism behind chemotherapy-induced peripheral neuropathy

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, according to a new study by Weill Cornell Medicine and Wake Forest University School of Medicine researc... Read more

Medical News - Nov 21

First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase 3 TROPION-Breast02 trial

Emerging Trends to Drive Chemotherapy-Induced Anemia Market Growth at 7.9% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.Chemotherapy-Induced Anemia Market Size Growth Forecast: What to Expect by 2025?The market related to chemotherapy-induced anemia has demonstrated Read more

Openpr.com - Nov 14

Lutetium Lu 177 Vipivotide Tetraxetan Enables Some Patients with mCRPC to Avoid Chemotherapy

Chemotherapy-Induced Anemia Market Revenue Forecast and Expansion Potential in North America and Europe

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ES... Read more

Openpr.com - Nov 05

Browse the latest chemotherapy news online for free